Company intelligence
Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
Where the medicine of tomorrow begins. We strive for excellence in biomedical research to improve people's health
About Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
The Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) carries out excellent biomedical research and investigates the most common diseases in our society. Our mission is translational research; that is, we look to ensure that the questions that arise at the patient’s bedside find answers in the laboratory and that advances made in the laboratory are translated rapidly to the patient. Approximately 2,000 professionals work out at our institution. Around 100 multidisciplinary groups carry out relevant research, as demonstrated by more than 1,500 original articles published every year. IDIBAPS is one of the leading biomedical research centers in Spain with an international projection. IDIBAPS is the result of the integration in 2023 of the Hospital Clínic Foundation for Biomedical Research (FCRB), created in 1989, and the consortium August Pi i Sunyer Biomedical Research Institute, created in 1996. It is a nonprofit foundation with a board of governors representing the Catalan Government departments of Health and of Research and Universities, Clínic Barcelona Hospital and the University of Barcelona. IDIBAPS is a CERCA center and has been accredited as a healthcare research institute by the Carlos III Institute of Health since 2009. It is also part of the Science Foundation Centers of the Spanish Cancer Association (AECC) and of the Network of Hospital and Biosanitary Clinical Research Management Institutions (REGIC).
Verified activity
Signals from Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
2 published signals
Research & Knowledge
Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) published a study in The European Journal of Health Economics showing that kidney transplant recipients can safely continue recovery at home under specialist medical supervision, achieving clinical outcomes comparable to conventional hospitalization while reducing hospital stay from 9 to 5 days.
Reported by Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
Research & Knowledge
Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) published a study in BloodAdvances revealing genetic, biological, and clinical differences between IRF4-rearranged large B-cell lymphomas diagnosed in children, adolescents, and young adults and those occurring in adults over 40 years of age.
Reported by Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)